FOR IMMEDIATE RELEASE:
April 13, 2026

Media Contact:
Samantha Tirado
Director of Policy Communications 
stirado@mgma.org 
 

MGMA Statement 2026 CMS Interoperability Standards and Prior Authorization for Drugs Proposed Rule (April 13, 2026)

Anders Gilberg
Senior Vice President, Government Affairs
Medical Group Management Association

“Physician practices face a daily deluge of insurance prior authorization requests, many of which involve prescription drugs. This newly proposed rule builds on the Administration's positive momentum to hold Medicare Advantage, Medicaid, and other insurers accountable for abusive prior authorization tactics. MGMA is concerned with the potential for further expansion of prior authorization into traditional Medicare beyond CMMI's recent WISeR demonstration model. We will evaluate this proposal with these considerations in mind and look forward to responding during the comment period for the rule.”

###

About MGMA

Founded in 1926, the Medical Group Management Association (MGMA) is the nation's largest association focused on the business of medical practice management. MGMA consists of 15,000 group medical practices ranging from small private medical practices to large national health systems representing more than 350,000 physicians. MGMA helps nearly 60,000 medical practice leaders and the healthcare community solve the business challenges of running practices so that they can focus on providing outstanding patient care. Specifically, MGMA helps its members innovate and improve profitability and financial sustainability, and it provides the gold standard on industry benchmarks such as physician compensation. The association also advocates extensively on its members' behalf on national regulatory and policy issues.